Sumitomo Life Insurance Co. Has $2.51 Million Position in HCA Healthcare Inc (HCA)

Sumitomo Life Insurance Co. cut its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 10.2% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,282 shares of the company’s stock after selling 2,189 shares during the quarter. Sumitomo Life Insurance Co.’s holdings in HCA Healthcare were worth $2,514,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of HCA. Meeder Asset Management Inc. increased its holdings in shares of HCA Healthcare by 3.7% in the 1st quarter. Meeder Asset Management Inc. now owns 54,099 shares of the company’s stock valued at $7,053,000 after acquiring an additional 1,935 shares during the last quarter. First Manhattan Co. increased its holdings in shares of HCA Healthcare by 20.2% in the 1st quarter. First Manhattan Co. now owns 1,310 shares of the company’s stock valued at $170,000 after acquiring an additional 220 shares during the last quarter. Narwhal Capital Management increased its holdings in shares of HCA Healthcare by 2.2% in the 1st quarter. Narwhal Capital Management now owns 7,096 shares of the company’s stock valued at $925,000 after acquiring an additional 156 shares during the last quarter. Mercer Global Advisors Inc. ADV bought a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $948,000. Finally, OmniStar Financial Group Inc. increased its holdings in shares of HCA Healthcare by 2.9% in the 1st quarter. OmniStar Financial Group Inc. now owns 11,571 shares of the company’s stock valued at $1,509,000 after acquiring an additional 321 shares during the last quarter. Institutional investors own 71.37% of the company’s stock.

Shares of HCA stock opened at $114.12 on Wednesday. HCA Healthcare Inc has a 1 year low of $93.03 and a 1 year high of $147.42. The firm has a market cap of $39.29 billion, a price-to-earnings ratio of 11.68, a price-to-earnings-growth ratio of 1.06 and a beta of 0.78.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 29th. The company reported $2.99 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.59 by $0.40. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. The company had revenue of $12.27 billion during the quarter, compared to analyst estimates of $12.10 billion. During the same quarter in the previous year, the firm posted $2.12 EPS. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. Sell-side analysts expect that HCA Healthcare Inc will post 10.01 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 1st were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date was Thursday, February 28th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.35. HCA Healthcare’s payout ratio is 16.38%.

HCA has been the subject of a number of research analyst reports. Zacks Investment Research upgraded HCA Healthcare from a “hold” rating to a “buy” rating and set a $140.00 price target for the company in a report on Wednesday, December 19th. Deutsche Bank initiated coverage on HCA Healthcare in a report on Thursday, January 3rd. They issued a “buy” rating and a $140.00 price target for the company. Stephens initiated coverage on HCA Healthcare in a report on Monday, January 14th. They issued an “overweight” rating and a $143.00 price target for the company. Leerink Swann boosted their price target on HCA Healthcare from $160.00 to $175.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. Finally, SunTrust Banks boosted their price target on HCA Healthcare to $175.00 and gave the company a “buy” rating in a report on Wednesday, January 30th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and seventeen have issued a buy rating to the company. HCA Healthcare has an average rating of “Buy” and a consensus price target of $148.43.

In other news, SVP Deborah M. Reiner sold 523 shares of the company’s stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $138.89, for a total value of $72,639.47. Following the completion of the sale, the senior vice president now owns 4,927 shares in the company, valued at $684,311.03. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jon M. Foster sold 11,640 shares of the company’s stock in a transaction on Tuesday, February 12th. The shares were sold at an average price of $139.68, for a total value of $1,625,875.20. Following the completion of the sale, the insider now owns 84,492 shares of the company’s stock, valued at approximately $11,801,842.56. The disclosure for this sale can be found here. Insiders have sold a total of 78,476 shares of company stock valued at $10,940,008 in the last quarter. 2.70% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: “Sumitomo Life Insurance Co. Has $2.51 Million Position in HCA Healthcare Inc (HCA)” was originally posted by Modern Readers and is owned by of Modern Readers. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.modernreaders.com/news/2019/04/17/sumitomo-life-insurance-co-has-2-51-million-position-in-hca-healthcare-inc-hca.html.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What are the benefits of investing in REITs?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.